Literature DB >> 10147112

Cost-effectiveness of cost-effectiveness studies.

S Pashko.   

Abstract

Mesh：

Year:  1992        PMID： 10147112     DOI： 10.2165/00019053-199201040-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  1 in total

1.  The cost-effectiveness of idarubicin/cytosine arabinoside versus daunorubicin/cytosine arabinoside in the treatment of adults with acute myeloid leukemia.

Authors:  S Pashko; J Jacobs; J Santorsa
Journal:  Clin Ther       Date:  1991 May-Jun       Impact factor: 3.393
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.